Search results for "Statu"

showing 10 items of 2961 documents

Clinical Predictors of Response to Magnetic Seizure Therapy in Depression

2019

Objectives Magnetic seizure therapy (MST) is a novel convulsive brain stimulation method in clinical testing, which is used as an alternative for electroconvulsive therapy in patients with treatment-resistant depression (TRD). Preliminary studies have suggested that MST leads to fewer cognitive adverse effects than electroconvulsive therapy but has similar efficacy. However, the clinical predictors of response to MST have not been evaluated yet. This study aimed to investigate whether these predictors can be identified in patients with TRD. Methods Thirty-eight patients with TRD were included. As clinical predictors for treatment response, we used the diagnosis, sex, age, family history, an…

AdultMalemedicine.medical_specialtyAnhedoniaMagnetic Field Therapymedicine.medical_treatmentNeuroscience (miscellaneous)Depressive Disorder Treatment-Resistant03 medical and health sciences0302 clinical medicineElectroconvulsive therapyPredictive Value of TestsSeizuresInternal medicinemedicineHumansFamily historyAtypical depressionDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressionbusiness.industryHamilton Rating Scale for DepressionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomeMagnetic seizure therapyBrain stimulationAnxietyFemalemedicine.symptombusinesshuman activities030217 neurology & neurosurgeryThe Journal of ECT
researchProduct

Are media warnings about the adverse health effects of modern life self-fulfilling? An experimental study on idiopathic environmental intolerance att…

2013

article i nfo Objective: Medically unsubstantiated 'intolerances' to foods, chemicals and environmental toxins are com- mon and are frequently discussed in the media. Idiopathic environmental intolerance attributed to electro- magnetic fields (IEI-EMF) is one such condition and is characterized by symptoms that are attributed to exposure to electromagnetic fields (EMF). In this experiment, we tested whether media reports promote the development of this condition. Methods: Participants (N=147) were randomly assigned to watch a television report about the adverse health effects of WiFi (n=76) or a control film (n=71). After watching their film, participants received a sham exposure to a WiFi …

AdultMalemedicine.medical_specialtyAudiologyNeuropsychological TestsElectromagnetic hypersensitivitylaw.inventionElectromagnetic FieldsRandomized controlled trialIntoleranceslawAdverse health effectmedicineHumansMass MediaAdverse effectPsychiatrySomatoform DisordersPsychiatric Status Rating ScalesEnvironmental Exposuremedicine.diseaseIdiopathic environmental intolerancePsychiatry and Mental healthClinical PsychologyAnxietyFemaleTelevisionMultiple Chemical Sensitivitymedicine.symptomPsychologySomatizationElectromagnetic PhenomenaJournal of psychosomatic research
researchProduct

The Norwegian Healthy Life Centre Study: A pragmatic RCT of physical activity in primary care.

2018

Aims: The aim of this study was to evaluate the effect of behaviour change interventions at Norwegian Healthy Life Centres (HLCs) on participants’ moderate to vigorous intensity physical activity (MVPA) six months after baseline. We also explore predictors of change in MVPA, and if level of education and MVPA at baseline modify the effect. Methods: A randomised controlled trial with inclusion criteria age ⩾ 18 years and ability to participate in group-based physical activity. Participants were randomised to either behaviour change interventions or a waiting list (control). Objective recordings of physical activity were the main outcome, analysed with simple and multiple linear regression. …

AdultMalemedicine.medical_specialtyBehaviour changePhysical activityNorwegianPrimary carelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawBehavior TherapyIntervention (counseling)MedicineBehaviour change interventionsHumans030212 general & internal medicineExercise030505 public healthPrimary Health Carebusiness.industryNorwayPublic Health Environmental and Occupational HealthGeneral MedicineMiddle Agedlanguage.human_languageTreatment OutcomelanguagePhysical therapyEducational StatusFemaleSedentary Behavior0305 other medical sciencebusinesshuman activitiesFollow-Up StudiesScandinavian journal of public health
researchProduct

Cognitive impairment in Behçet's disease patients without overt neurological involvement

2003

We investigated the prevalence of cognitive impairment in patients with Behc¸et’s disease (BD) without overt neurological involvement. The influence of disease duration, disease activity, prednisone dosage, and anxiety and depression levels was evaluated. Twenty-six consecutive BD outpatients and 26 healthy controls matched for age, education and sex completed a comprehensive neuropsychological battery including tests of memory, visuospatial and constructional abilities, language, attention and psychomotor speed, non-verbal reasoning and executive functioning. The Hamilton scales for anxiety and depression were administered. Disease activity was assessed using the Behc¸et’s Disease Current …

AdultMalemedicine.medical_specialtyBehcet's diseaseNeuropsychological TestsNeuropsychologyPredictive Value of TestsPrednisoneInternal medicineOdds RatiomedicineCorticosteroidHumansAttentionDisease activityDepression (differential diagnoses)DemographyLanguagePsychiatric Status Rating ScalesPsychomotor learningVascular diseaseBehcet SyndromeCase-control studyNeuropsychologyVerbal Learningmedicine.diseaseCognitive impairmentMemory Short-TermNeurologyCase-Control StudiesPhysical therapyAnxietySettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomCognition DisordersPsychologyBehcet’s diseasePsychomotor Performancemedicine.drugJournal of the Neurological Sciences
researchProduct

Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life

2017

Objective To assess the impact of therapy on patients' health-related quality of life (HRQoL) in recurrent high-grade glioma (HGG) in an unselected cohort. Methods In this prospective multicenter study, we analyzed European Organization for Research and Treatment of Cancer Quality of Life core questionnaire and European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Brain Neoplasm module questionnaires of 92 patients within 1 year after diagnosis of tumor recurrence of a HGG and respective treatment. We evaluated the influence of re-radiation, second- and third-line chemotherapies, and number of recurrent surgeries on summary scores for functioning, symptoms…

AdultMalemedicine.medical_specialtyBevacizumabAntineoplastic AgentsProcarbazinelaw.inventionCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawSurveys and QuestionnairesInternal medicinemedicineHumansProspective StudiesKarnofsky Performance StatusAgedTemozolomidePerformance statusBrain Neoplasmsbusiness.industryCancerGliomaMiddle Agedmedicine.diseaseEurope030220 oncology & carcinogenesisCohortQuality of LifePhysical therapyFemaleRadiotherapy AdjuvantSurgeryNeurology (clinical)Neoplasm Recurrence Localbusiness030217 neurology & neurosurgerymedicine.drugWorld Neurosurgery
researchProduct

Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.

2009

Few studies have compared neurocognitive performance in euthymic patients with bipolar disorder (BD), stabilized patients with schizophrenia (SC) and normal controls (NC) using a comprehensive neuropsychological battery, and those that have been conducted have yielded discrepant results. We evaluated the neurocognitive profile shown by 73 euthymic patients with BD, 89 stabilized patients with SC and 67 NC. All participants completed a cognitive battery in which the domains evaluated were executive functioning, sustained attention, and verbal and visual memory. Individuals with BD were administered the Quality of Life Scale (QLS). Patients with BD manifested dysfunction in executive function…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentGlobal Assessment of FunctioningTrail Making TestAudiologyNeuropsychological TestsYoung AdultVisual memoryMemorymedicineMemory spanHumansPsychiatryBiological PsychiatryProblem SolvingPsychiatric Status Rating ScalesCalifornia Verbal Learning TestChi-Square DistributionMiddle Agedmedicine.diseasePsychiatry and Mental healthSchizophreniaMultivariate AnalysisSchizophreniaFemaleSchizophrenic PsychologyVerbal memoryPsychologyCognition DisordersNeurocognitivePsychiatry research
researchProduct

The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients

2013

Abstract Background The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to administer scale developed for screening cognitive deficits. This study presents the diagnostic-specific standardization data for this scale in a sample of schizophrenia and bipolar I disorder patients. Methods Patients between 18 and 55 years who are in a stable phase of the disease, diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or bipolar I disorder were enrolled in this study. Results The SCIP-S was administered to 514 patients (57.9% male), divided into two age groups (18–39 and 40–55 years) and two educational level groups (less than and secondary or…

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar I disorderAdolescentNormsSchizoaffective disorderSCIP-SDiseaseNeuropsychological TestsYoung AdultCognitionmental disordersmedicineHumansBipolar I disorderBipolar disorderYoung adultSchizophreniform disorderPsychiatryLanguagePsychiatric Status Rating ScalesPsychiatrybusiness.industryReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseStandardization dataPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleCognition DisordersbusinessResearch ArticleClinical psychologyBMC Psychiatry
researchProduct

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis

2013

© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar disorderTrail Making TestReviewNeuropsychological TestsVerbal learning03 medical and health sciencesMental Processes0302 clinical medicineRisk FactorsmedicineMemory spanHumansMental CompetencyAffective SymptomsBipolar disorderAge of OnsetPsychiatryPsychiatric Status Rating ScalesPsychotropic DrugsNeuropsychologyConfounding Factors EpidemiologicMiddle Agedmedicine.disease030227 psychiatryAffectPsychiatry and Mental healthMoodCognitive impairmentSchizophreniaNeuropsychological testsFemaleVerbal memoryCognition DisordersPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Treatment nonadherence and neurocognitive impairment in bipolar disorder.

2009

OBJECTIVE: Little is known regarding the relationship between treatment adherence and residual cognitive dysfunction in euthymic bipolar disorder patients. This study aimed to investigate whether poor treatment adherence is associated with cognitive impairment in euthymic bipolar patients and whether other factors may be associated with both adherence and cognitive functioning. METHOD: Euthymic DSM-IV bipolar I or II disorder patients (N = 103: 61 with high levels of treatment adherence and 42 with poor treatment adherence) were assessed using a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions and compared with 35 healthy controls of …

AdultMalemedicine.medical_specialtyBipolar DisorderComorbidityNeuropsychological TestsYoung Mania Rating ScaleVerbal learningSeverity of Illness IndexMemorymedicineHumansBipolar disorderPsychiatryPsychiatric Status Rating ScalesCognitive disorderHamilton Rating Scale for DepressionVerbal Learningmedicine.diseaseExecutive functionsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPatient ComplianceFemaleVerbal memoryPsychologyCognition DisordersLithium ChlorideNeurocognitivePsychomotor PerformanceClinical psychologyThe Journal of clinical psychiatry
researchProduct

Clinical factors leading to lamotrigine prescription in bipolar outpatients: Subanalysis of the SIN-DEPRES study

2012

Abstract Background The use of lamotrigine is a point of discrepancy among the diverse guidelines published on the management of bipolar disorder (BD). Evidence supporting the long-term efficacy is reasonably robust. Nonetheless, the effectiveness of lamotrigine in acute treatment is vigorously debated and it is unclear how this drug is used in routine clinical practice. This subanalysis of the SIN-DEPRES study was designed to understand the clinical profile of bipolar patients receiving lamotrigine. Methods In this prospective national multicenter study, 652 patients with clinically stable bipolar I and II disorder were recruited. Clinical assessments included sociodemographic and clinical…

AdultMalemedicine.medical_specialtyBipolar DisorderLamotrigineLamotrigineLogistic regressionBipolar II disorderAntimanic AgentsRating scaleInternal medicineOutpatientsmedicineHumansProspective StudiesBipolar disorderMedical prescriptionPsychiatryDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderTriazinesbusiness.industryMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyClinical Global ImpressionRegression AnalysisFemaleGuideline Adherencebusinessmedicine.drugJournal of Affective Disorders
researchProduct